Clinical Trial: Efficacy and Safety of Modafinil to Treat Fatigue in People With Mitochondrial Disease.

U.S., Oct. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07887412) titled 'Efficacy and Safety of Modafinil to Treat Fatigue in People With Mitochondrial Disease.' on Oct. 14.

Brief Summary: Mitochondrial diseases are genetic disorders that affect the body's ability to produce energy. Fatigue is a common symptom that can significantly affect daily activities, physical functioning, and quality of life. This study will evaluate whether modafinil, a medication used to promote wakefulness, can improve fatigue and physical endurance in people with mitochondrial disease. The study will also assess the safety and tolerability of modafinil in this population.

Fatigue prevents patients from engaging in activities ...